New Study Links Common Cholesterol Drug to Lower Heart Risk in Rare Heart Attack Type
A large, real-world cohort study published in December 2025 found that the anti-inflammatory drug Colchicine is associated with significantly reduced rates of cardiovascular events in patients who suffer a less […]
